Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, July 2005, p. 3091-3094, Vol. 49, No. 7
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.7.3091-3094.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Association of Plasmid-Mediated Quinolone Resistance with Extended-Spectrum ß-Lactamase VEB-1
Laurent Poirel,
Marc Van De Loo,
Hedi Mammeri, and
Patrice Nordmann*
Service de Bactériologie-Virologie, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine Paris-Sud, Université Paris XI, 94275 Le Kremlin-Bicêtre, France
Received 10 December 2004/
Returned for modification 5 February 2005/
Accepted 12 March 2005

ABSTRACT
Association of the plasmid-mediated quinolone resistance determinant
QnrA and the
blaVEB-1 gene was identified in a single
Enterobacter cloacae isolate from K.-Bicêtre, France, and in 11 out
of 23
blaVEB-1-positive enterobacterial isolates from Bangkok,
Thailand. This result may explain in part the association between
quinolone and extended-spectrum ß-lactam resistance.

TEXT
Quinolone resistance results mostly from chromosomal mutations
in genes coding for DNA gyrase and topoisomerase IV and from
changes in outer membrane or efflux proteins or their regulatory
mechanisms in
Enterobacteriaceae (
28). However, plasmid-mediated
resistance to quinolone was first reported in 1998 for a
Klebsiella pneumoniae isolate from the United States (
11). The plasmid-encoded
protein responsible for resistance, named Qnr (and recently
termed QnrA [A. Robicsek, D. F. Sahm, G. Jacoby, and D. C. Hooper,
Abstr. 44th Intersci. Conf. Antimicrob. Agents Chemother., abstr.
C2-1898a, 2004]), protects DNA gyrase and topoisomerase IV from
the inhibitory activity of quinolones (
29; J. H. Tran, G. A.
Jacoby, and D. C. Hooper, Abstr. 43rd Intersci. Conf. Antimicrob.
Agents Chemother, abstr. C1-604, 2003). It confers resistance
to nalidixic acid and increases fluoroquinolone MICs up to 32-fold
(
9,
11,
30,
31).
qnrA-positive isolates are increasingly identified
in the United States (
7,
30), and there are scattered reports
of their presence in Asia (
31) and Europe (
8,
9). Several
qnrA-positive
isolates produced clavulanic acid-inhibited extended-spectrum
ß-lactamases (ESBL) such as SHV-7 and CTX-M-9 (
31).
In a previous study, we reported a single qnrA-positive Escherichia coli isolate that produced the ESBL VEB-1 among nalidixic acid-resistant E. coli isolates at the Bicêtre Hospital in 2003 (9). The main goal of the present study was to search for QnrA determinants among nalidixic acid-resistant isolates (n = 152) belonging to other enterobacterial species from the same hospital and to search for any association between QnrA and VEB-1 among other characterized isolates. A series of blaVEB-1-positive and blaVEB-1-negative nonreplicate isolates from Thailand and strains that contained other reference ß-lactamases were screened (Table 1). A qnrA-like gene was searched for by PCR using previously reported primers (9, 31). A qnrA-like gene was detected in a single Enterobacter cloacae isolate (GOC) among all nalidixic acid-resistant isolates from Bicêtre Hospital in 2003. The estimated prevalence of this gene was 4% among ESBL-positive enterobacterial isolates (n = 24). E. cloacae GOC was isolated in January 2003 from the urine of a 22-year-old man who had multiple urinary tract infections due to cystic diverticulosis and who was treated successively with ciprofloxacin and imipenem. A qnrA-like gene was also detected in 11 out of 23 blaVEB-1-positive enterobacterial isolates (48%) from Bangkok in 1999 (Table 1). It was identified in Enterobacter sakazakii and constituted the first description of the gene in that species (Table 2). Sequence analysis of the PCR-amplified products identified the same qnrA gene in all cases (29). No qnrA-like gene was identified either in blaVEB-1-positive enterobacterial isolates from any country except France and Thailand, in ESBL-positive, blaVEB-1-negative enterobacterial isolates from Thailand, in blaVEB-1-positive Pseudomonas aeruginosa isolates from Thailand, or in other strains that contained reference ß-lactamase genes (Table 1). These results showed that the blaVEB-1 gene was frequently but not systematically associated with a QnrA determinant, and only in Enterobacteriaceae.
View this table:
[in this window]
[in a new window]
|
TABLE 2. MICs of quinolones for clinical isolates carrying the qnrA gene, their transconjugants (Tc strains), and the E. coli J53 recipient straina
|
Conjugations were carried out by a filter mating technique with
E. coli J53 Az
R as the recipient, as previously described (
9).
Conjugation experiments yielded
qnrA-positive transconjugants
for
E. cloacae GOC and for most of the
qnrA-positive enterobacterial
isolates from Thailand except for
E. coli E2,
E. coli E10, and
E. sakazakii E15 (Table
2). Electrophoresis of the plasmid extracts
from these latter isolates and from the transconjugants obtained
with the other clinical isolates as donors was followed by Southern
hybridization, as described elsewhere (
9,
21). The probes consisted
of a 661-bp fragment for
qnrA and a 627-bp fragment for
blaVEB-1 (
9). Each strain contained a single plasmid that cohybridized
with
qnrA- and
veb-1-specific probes (Fig.
1). The molecular
sizes of the plasmids ranged from 130 to 200 kb (Fig.
1; Table
2).
Disk diffusion susceptibility testing and MIC determinations,
performed as described elsewhere (
9), showed that transconjugants
were resistant to nalidixic acid, chloramphenicol, tobramycin,
sulfonamides, and most ß-lactams, including ampicillin,
cefotaxime, and ceftazidime. Resistance to trimethoprim was
cotransferred only in transconjugant TcE3 (Table
2). Whereas
transconjugants were always resistant to nalidixic acid, clinical
isolates 7, 10, and 18 were susceptible (Table
2). These results
are reminiscent of a previous study indicating that the QnrA
determinant may be expressed at variable levels, possibly depending
on host functions (
10). As shown previously, combined mechanisms
of resistance might explain resistance to fluoroquinolones in
the
qnrA-positive clinical strains (
9-
11).
Using a series of specific primers (3, 5, 12, 13, 14, 18, 20), the blaVEB-1 and blaOXA-10 genes were identified in all qnrA-positive isolates. Both of these ß-lactamase genes were located in a class 1 integron that has been characterized in detail previously (5, 9, 26). Using a PCR-based strategy, the structures of the qnrA-type-containing integrons identified from the resistance plasmids of the 12 enterobacterial isolates reported in this study were determined. The qnrA-like gene was located in sul1-type class 1 integrons. It was bracketed by a duplication of the 3' conserved sequence region of the class 1 integron and was not associated with a 59-bp element as reported previously (9). These sul1-type integrons were almost identical, at least in their central regions, to the sul1-type integron of pQR1 from the E. coli Lo strain previously found at the Bicêtre Hospital (Fig. 2), (9). A 2-bp deletion was found at the right boundary of the CR1 element that contained orf513 compared to the structure identified in pMG252 (Fig. 2) (31). This result indicated that the mobilization mechanism of the qnrA gene mediated by CR1 may vary. Further PCR amplifications revealed that strains 1, 4, 5, and GOC contained another copy of the orf513 gene immediately downstream of the sul1-type integron, whereas this orf513 duplication was not found for strains 2, 3, 7, 8, 10, 15, 16, and 18 (Fig. 2).
This study further underlines the spread of the QnrA determinant
in Europe (being the second report from France [
9]) and in Southeast
Asia. Association of the
qnrA and
blaVEB-1 genes may account
in part for the association between expanded-spectrum cephalosporins
and fluoroquinolone resistance (
16). Finally, identification
of QnrA-positive and nalidixic acid-susceptible clinical isolates
raised concern about a hidden spread of this resistance determinant.
Nucleotide sequence accession numbers.
The nucleotide sequences reported here have been assigned accession numbers AY931017 and AY931018.

ACKNOWLEDGMENTS
This work was funded by a grant from the Ministère de
l'Education Nationale et de la Recherche (UPRES-EA3539), Université
Paris XI, France, and by the European Community (6th PCRD, LSHM-CT-2003-503-335).
L.P. is a researcher from INSERM, Paris, France.

FOOTNOTES
* Corresponding author. Mailing address: Service de Bactériologie-Virologie, Hôpital de Bicêtre, 78 rue du Général Leclerc, 94275 Le Kremlin-Bicêtre cedex, France. Phone: 33-1-45-21-36-32. Fax: 33-1-45-21-63-40. E-mail:
nordmann.patrice{at}bct.ap-hop-paris.fr.


REFERENCES
1 - Aubert, D., D. Girlich, T. Naas, S. Nagarajan, and P. Nordmann. 2004. Functional and structural characterization of the genetic environment of an extended-spectrum ß-lactamase blaVEB gene from a Pseudomonas aeruginosa isolate obtained in India. Antimicrob. Agents Chemother. 48:3284-3290.[Abstract/Free Full Text]
2 - Aubron, C., L. Poirel, R. J. Ash, and P. Nordmann. 2005. Carbapenemase-producing Enterobacteriaceae, U.S. rivers. Emerg. Infect. Dis. 11:260-264.[Medline]
3 - Fortineau, N., L. Poirel, and P. Nordmann. 2001. Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae. J. Antimicrob. Chemother. 47:207-210.[Abstract/Free Full Text]
4 - Girlich, D., T. Naas, A. Leelaporn, L. Poirel, M. Fennewald, and P. Nordmann. 2002. Nosocomial spread of the integron-located veb-1-like cassette encoding an extended-spectrum ß-lactamase in Pseudomonas aeruginosa in Thailand. Clin. Infect. Dis. 34:603-611.[CrossRef][Medline]
5 - Girlich, D., L. Poirel, A. Leelaporn, A. Karim, C. Tribuddharat, M. Fennewald, and P. Nordmann. 2001. Molecular epidemiology of the integron-located VEB-1 extended-spectrum ß-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J. Clin. Microbiol. 39:175-182.[Abstract/Free Full Text]
6 - Héritier, C., L. Poirel, D. Aubert, and P. Nordmann. 2003. Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrob. Agents Chemother. 47:268-273.[Abstract/Free Full Text]
7 - Jacoby, G. A., N. Chow, and K. B. Waites. 2003. Prevalence of plasmid mediated quinolone resistance. Antimicrob. Agents Chemother. 47:559-562.[Abstract/Free Full Text]
8 - Jonas, D., K. Biehler, D. Hartung, B. Spitzmüller, and F. D. Daschner. 2005. Plasmid-mediated quinolone resistance in isolates obtained in German intensive care units. Antimicrob. Agents Chemother. 49:773-775.[Abstract/Free Full Text]
9 - Mammeri, H., M. Van De Loo, L. Poirel, L. Martinez-Martinez, and P. Nordmann. 2005. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob. Agents Chemother. 49:71-76.[Abstract/Free Full Text]
10 - Martinez-Martinez, L., A. Pascual, I. Garcia, J. Tran, and G. A. Jacoby. 2003. Interaction of plasmid and host quinolone resistance. J. Antimicrob. Chemother. 51:1037-1039.[Free Full Text]
11 - Martinez-Martinez, L., A. Pascual, and G. A. Jacoby. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797-799.[CrossRef][Medline]
12 - Naas, T., F. Benaoudia, S. Massuard, and P. Nordmann. 2000. Integron-located VEB-1 extended-spectrum ß-lactamase gene in a Proteus mirabilis clinical isolate from Vietnam. J. Antimicrob. Chemother. 46:703-711.[Abstract/Free Full Text]
13 - Naas, T., L. Philippon, L. Poirel, E. Ronco, and P. Nordmann. 1999. An SHV-derived extended-spectrum ß-lactamase in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:1281-1284.[Abstract/Free Full Text]
14 - Naas, T., W. Sougakoff, A. Casetta, and P. Nordmann. 1998. Molecular characterization of OXA-20, a novel class D ß-lactamase, and its integron from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 42:2074-2083.[Abstract/Free Full Text]
15 - Nordmann, P., E. Ronco, T. Naas, C. Duport, Y. Michel-Briand, and R. Labia. 1993. Characterization of a novel extended-spectrum ß-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 37:962-969.[Abstract/Free Full Text]
16 - Paterson, D. L., L. Mulazimoglu, J. M. Casellas, W. C. Ko, H. Goosens, A. Von Gottberg, S. Mohapatra, G. M. Trenholme, K. P. Klugman, J. G. McCormack, and V. L. Yu. 2000. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum ß-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin. Infect. Dis. 30:473-478.[CrossRef][Medline]
17 - Philippon, L. N., T. Naas, A. T. Bouthors, V. Barakett, and P. Nordmann. 1997. OXA-18, a class D clavulanic acid-inhibited extended-spectrum ß-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41:2188-2195.[Abstract]
18 - Poirel, L., P. Gerome, C. De Champs, J. Stephanazzi, T. Naas, and P. Nordmann. 2002. Integron-located OXA-32 gene cassette encoding an extended-spectrum variant of OXA-2 ß-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 46:566-569.[Abstract/Free Full Text]
19 - Poirel, L., D. Girlich, T. Naas, and P. Nordmann. 2001. OXA-28, an extended-spectrum variant of OXA-10 ß-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene. Antimicrob. Agents Chemother. 45:447-453.[Abstract/Free Full Text]
20 - Poirel, L., C. Héritier, V. Tolün, and P. Nordmann. 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:15-22.[Abstract/Free Full Text]
21 - Poirel, L., I. Le Thomas, T. Naas, A. Karim, and P. Nordmann. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum ß-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44:622-632.[Abstract/Free Full Text]
22 - Poirel, L., O. Menuteau, N. Agoli, C. Cattoen, and P. Nordmann. 2003. Outbreak of extended-spectrum ß-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J. Clin. Microbiol. 41:3542-3547.[Abstract/Free Full Text]
23 - Poirel, L., T. Naas, M. Guibert, E. B. Chaibi, R. Labia, and P. Nordmann. 1999. Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum ß-lactamase encoded by an Escherichia coli integron gene. Antimicrob. Agents Chemother. 43:573-581.[Abstract/Free Full Text]
24 - Poirel, L., T. Naas, I. Le Thomas, A. Karim, E. Bingen, and P. Nordmann. 2001. CTX-M-type extended-spectrum ß-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrob. Agents Chemother. 45:3355-3361.[Abstract/Free Full Text]
25 - Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J. D. Cavallo, and P. Nordmann. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-ß-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897.[Abstract/Free Full Text]
26 - Poirel, L., V. O. Rotimi, E. M. Mokaddas, A. Karim, and P. Nordmann. 2001. VEB-1-like extended-spectrum ß-lactamases in Pseudomonas aeruginosa, Kuwait. Emerg. Infect. Dis. 7:468-470.[Medline]
27 - Poirel, L., G. F. Weldhagen, T. Naas, C. De Champs, M. G. Dove, and P. Nordmann. 2001. GES-2, a class A ß-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob. Agents Chemother. 45:2598-2603.[Abstract/Free Full Text]
28 - Ruiz, J. 2003. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemother. 51:1109-1117.[Abstract/Free Full Text]
29 - Tran, J. H., and G. A. Jacoby. 2002. Mechanism of plasmid-mediated quinolone resistance. Proc. Natl. Acad. Sci. USA 99:5638-5642.[Abstract/Free Full Text]
30 - Wang, M., D. F. Sahm, G. A. Jacoby, and D. C. Hooper. 2004. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob. Agents Chemother. 48:1295-1299.[Abstract/Free Full Text]
31 - Wang, M., J. H. Tran, G. A. Jacoby, Y. Zhang, F. Wang, and D. C. Hooper. 2003. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob. Agents Chemother. 47:2242-2248.[Abstract/Free Full Text]
Antimicrobial Agents and Chemotherapy, July 2005, p. 3091-3094, Vol. 49, No. 7
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.7.3091-3094.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Tamang, M. D., Seol, S. Y., Oh, J.-Y., Kang, H. Y., Lee, J. C., Lee, Y. C., Cho, D. T., Kim, J.
(2008). Plasmid-Mediated Quinolone Resistance Determinants qnrA, qnrB, and qnrS among Clinical Isolates of Enterobacteriaceae in a Korean Hospital. Antimicrob. Agents Chemother.
52: 4159-4162
[Abstract]
[Full Text]
-
Cattoir, V., Poirel, L., Rotimi, V., Soussy, C.-J., Nordmann, P.
(2007). Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother
60: 394-397
[Abstract]
[Full Text]
-
Manzur, A., Tubau, F., Pujol, M., Calatayud, L., Dominguez, M. A., Pena, C., Sora, M., Gudiol, F., Ariza, J.
(2007). Nosocomial Outbreak Due to Extended-Spectrum-Beta-Lactamase- Producing Enterobacter cloacae in a Cardiothoracic Intensive Care Unit. J. Clin. Microbiol.
45: 2365-2369
[Abstract]
[Full Text]
-
Rodriguez-Martinez, J. M., Velasco, C., Garcia, I., Cano, M. E., Martinez-Martinez, L., Pascual, A.
(2007). Mutant Prevention Concentrations of Fluoroquinolones for Enterobacteriaceae Expressing the Plasmid-Carried Quinolone Resistance Determinant qnrA1. Antimicrob. Agents Chemother.
51: 2236-2239
[Abstract]
[Full Text]
-
Poirel, L., Cattoir, V., Soares, A., Soussy, C.-J., Nordmann, P.
(2007). Novel Ambler Class A {beta}-Lactamase LAP-1 and Its Association with the Plasmid-Mediated Quinolone Resistance Determinant QnrS1. Antimicrob. Agents Chemother.
51: 631-637
[Abstract]
[Full Text]
-
Poirel, L., Leviandier, C., Nordmann, P.
(2006). Prevalence and Genetic Analysis of Plasmid-Mediated Quinolone Resistance Determinants QnrA and QnrS in Enterobacteriaceae Isolates from a French University Hospital. Antimicrob. Agents Chemother.
50: 3992-3997
[Abstract]
[Full Text]
-
Chen, Y.-T., Shu, H.-Y., Li, L.-H., Liao, T.-L., Wu, K.-M., Shiau, Y.-R., Yan, J.-J., Su, I.-J., Tsai, S.-F., Lauderdale, T.-L.
(2006). Complete Nucleotide Sequence of pK245, a 98-Kilobase Plasmid Conferring Quinolone Resistance and Extended-Spectrum-{beta}-Lactamase Activity in a Clinical Klebsiella pneumoniae Isolate. Antimicrob. Agents Chemother.
50: 3861-3866
[Abstract]
[Full Text]
-
Poirel, L., Pitout, J. D. D., Calvo, L., Rodriguez-Martinez, J.-M., Church, D., Nordmann, P.
(2006). In Vivo Selection of Fluoroquinolone-Resistant Escherichia coli Isolates Expressing Plasmid-Mediated Quinolone Resistance and Expanded-Spectrum {beta}-Lactamase.. Antimicrob. Agents Chemother.
50: 1525-1527
[Abstract]
[Full Text]
-
Poirel, L., Rodriguez-Martinez, J.-M., Mammeri, H., Liard, A., Nordmann, P.
(2005). Origin of Plasmid-Mediated Quinolone Resistance Determinant QnrA. Antimicrob. Agents Chemother.
49: 3523-3525
[Abstract]
[Full Text]